DRUG SURVIVAL AND REASONS FOR DISCONTINUATION OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE (IBD) IN CLINICAL PRACTICE

Javier Gisbert  1     Miguel Arredondo  2     Maria Chaparro Sanchez  3     Iciar Cañamares     Esteban Daudén     Gema Fernández-Jiménez     Virginia Meca     Alberto Morell     Javier Aspa     Loreto Carmona     Jose Alvaro-Gracia    
1 Gastroenterology Unit, Hospital De La Princesa, Ciberehd And Ip, Madrid, Spain;biologic Therapies Unit, Hospital De La Princesa, Madrid, Spain
2 Documentation Service, Hospital De La Princesa, Madrid, Spain;biologic Therapies Unit, Hospital De La Princesa, Madrid, Spain
3 Gastroenterology Unit, Hospital De La Princesa, Ciberehd And Ip, M

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing